Psychedelics in psychiatry: from promise to translation.
Where this comes from
- Record sourced from PubMed, PMID 42572968.
- Also identified by DOI 10.1192/bjp.2026.10749.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Psychedelics hold promise for psychiatry, yet clinical translation remains premature. Addressing the challenges of psychedelics in psychiatry requires advances in mechanistic study, clinical implementation, regulatory governance and public discourse in parallel.